October 2020 Issue Table Of Contents
Source: Life Science Leader

From The Editor
Feature Articles
Capitol Perspectives
CEO Corner
- Hiring C-Suite Leadership During The Pandemic
- How The Right Culture Leads To Highly Productive Teams
Companies To Watch
From Policy to Execution
Patient Perspectives
Industry Research
Inside The Industry
- Why COGs Will Demand More Attention From Biosimilar Makers
- Changing The Status Quo Regarding Diversity In Clinical Trials
- COVID Revs Up The Antibiotics Space
- Using McKinsey’s 7-S Framework To Achieve Quality Culture
- Women In Bio Riding The Waves Of Change
- What Makes Outsourcers Very Satisfied?
Leadership Lessons
Ask The Board
- What — If Any — Silver Linings Have You Observed Taking Place At Your Company Resulting From The Chaos Caused By COVID-19?
- What’s Your Perspective On The Rise Around Virtual Pitching To Investors, And What Will Be Its Impact On Annual Investor Meetings Like The Biotech Showcase And JPM In 2021?
- What Is Your Biggest Concern Regarding The Biopharma Industry’s Reputation With The American People If We Don’t Have A COVID-19 Vaccine By The End Of This Year?
This website uses cookies to ensure you get the best experience on our website. Learn more